Education, prevention strategies and monitoring serves this at-risk group
Collaboration was key to identifying source of nerve condition
Guidance for the 5% to 20% of patients with suboptimal response or tolerability
Early results suggest positive outcomes from COVID-19 PrEP treatment
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First reported case in a patient with diffuse cutaneous systemic sclerosis
Combination therapy shows promise in pediatric patient population